[COMPLETE ABSTRACT AVAILABLE AT CHESTJOURNAL.ORG] 

First published online on January 15, 2008
Chest, doi:10.1378/chest.07-1949
doi:10.1378/chest.07-1949
(Chest. 2008; 133:653-661)
© 2008 American College of Chest Physicians

New Definition and Natural History of Patients With Diffuse Pulmonary Arteriovenous Malformations*
 

Twenty-Seven–Year Experience

Paola Pierucci, MD; Joshua Murphy, MD; Katharine J. Henderson, MS; Deborah A. Chyun, MSN, PhD, RN and Robert I. White, Jr, MD

* From the Department of Respiratory Medicine (Dr. Pierucci), School of Medicine, Policlinic of Bari, Bari, Italy; Department of Pediatrics, Section of Cardiology (Dr. Murphy), and Department of Diagnostic Radiology, Section of Interventional Radiology (Ms. Henderson and Dr. White), Yale University School of Medicine, New Haven, CT; and Yale University School of Nursing (Dr. Chyun), New Haven, CT.

Correspondence to: Katharine J. Henderson, MS, Yale University School of Medicine, Department of Diagnostic Radiology, 333 Cedar St, Room 5039 LMP, New Haven, CT 06520; e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Abstract

Background: Patients with diffuse pulmonary arteriovenous malformations (PAVM), a small but important subset of the PAVM population, have significant morbidity and mortality rates.

Methods: Thirty-six patients (21 female and 15 male) with diffuse PAVM from a cohort of 821 consecutive patients with PAVM were evaluated. Diffuse PAVM were categorized angiographically: involvement of one or more segmental pulmonary arteries in one or both lungs. Hereditary hemorrhagic telangiectasia (HHT) status, gender, presence or absence of large ( 3-mm diameter artery) focal PAVM, oxygen saturations, complications including hemoptysis, years of follow-up, and survival were tabulated.

Results: HHT was present in 29 of 36 patients (81%), and diffuse PAVM were more commonly bilateral (26 of 36 patients, 72%) than unilateral (10 of 36 patients, 28%) [p = 0.02]. Female gender was associated with bilateral diffuse PAVM (19 of 26 patients, 73%) [p = 0.01]. Focal PAVM were present in both groups but more commonly in patients with bilateral involvement (16 of 26 patients, 62%) [p = 0.02]. Initial oxygen saturations (pulse oximetry, standing) of patients with unilateral and bilateral diffuse PAVM were 87 ± 7% and 79 ± 8% (mean ± SD), respectively (p = 0.02). The last or current values for patients with unilateral and bilateral involvement are 95 ± 3% and 85 ± 7%, respectively (p < 0.0001). Nine deaths occurred, and all were in patients with bilateral involvement. Deaths were due to hemoptysis of bronchial artery origin (n = 2), hemorrhage from duodenal ulcer (n = 1), spontaneous liver necrosis (n = 3), brain hemorrhage (n = 1), brain abscess (n = 1), and operative death during attempted lung transplant (n = 1).

Conclusions: Patients with diffuse PAVM are a high-risk group, and yearly follow-up is recommended.

Key Words: arteriovenous malformations • diffuse • hereditary hemorrhagic telangiectasia • pulmonary angiography • transcatheter embolization

[COMPLETE ABSTRACT AVAILABLE AT CHESTJOURNAL.ORG]